Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway.
about
Mechanisms of the noxious inflammatory cycle in cystic fibrosisRelation of exaggerated cytokine responses of CF airway epithelial cells to PAO1 adherenceContribution of Burkholderia cenocepacia flagella to infectivity and inflammation.Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy studyPotential of anti-inflammatory treatment for cystic fibrosis lung disease.Lung inflammation as a therapeutic target in cystic fibrosis.Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection.Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms.Long acting beta2-agonist and corticosteroid restore airway glandular cell function altered by bacterial supernatant.Downregulation by a long-acting beta2-adrenergic receptor agonist and corticosteroid of Staphylococcus aureus-induced airway epithelial inflammatory mediator production.Inhibition by salmeterol and cilomilast of fluticasone-enhanced IP-10 release in airway epithelial cells.Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis.RDP58 is a novel and potentially effective oral therapy for ulcerative colitis.
P2860
Q21284420-92A47373-D1CD-4547-B05C-959141B2FEEEQ24813793-AE7151A9-BD15-4897-8D12-18A3B25D645FQ30434266-8EC5CE94-23EB-498E-A0AF-38DD0293DB51Q33573525-BD8CAC09-7781-4D47-89ED-5407DC34EFD1Q35557381-04CA5D1A-1451-4C81-B4FD-AF276A277324Q35894285-58186AEA-A6D4-44C0-B092-D024F65660D7Q37421441-D24A4BB2-F34E-44FD-822D-4137761C395BQ39567122-60132956-F11B-4A81-8ED3-4829E1379F5EQ39749920-E946880C-122D-461F-A433-3B461E7AF8A2Q40314061-15BE5C0E-A6B3-4BCA-B652-C4A31A3305C9Q46764756-2D531BE8-97DC-4CF4-93B6-25708F747E62Q48430924-EF6CE70D-AE3A-41D7-B456-D92517FDD691Q52565403-0B70B7C8-2442-4331-A3EF-78D873901C24
P2860
Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Fluticasone reduces IL-6 and I ...... s via IKK-beta kinase pathway.
@en
Fluticasone reduces IL-6 and I ...... s via IKK-beta kinase pathway.
@nl
type
label
Fluticasone reduces IL-6 and I ...... s via IKK-beta kinase pathway.
@en
Fluticasone reduces IL-6 and I ...... s via IKK-beta kinase pathway.
@nl
prefLabel
Fluticasone reduces IL-6 and I ...... s via IKK-beta kinase pathway.
@en
Fluticasone reduces IL-6 and I ...... s via IKK-beta kinase pathway.
@nl
P2093
P1476
Fluticasone reduces IL-6 and I ...... ls via IKK-beta kinase pathway
@en
P2093
C Majer-Teboul
E Puchelle
P304
P356
10.1183/09031936.03.00031803
P577
2003-04-01T00:00:00Z